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ABSTRACT

Ascaulitoxin aglycone is a structurally unique bis-amino acid isolated from the fungal
species Ascochyta caulina, with herbicidal activity against Chenopodium album. Ascaulitoxin
aglycone’s potent herbicidal activity coupled with an unknown but novel mechanism of action
makes it a perfect candidate for further study in the pursuit of new natural product herbicides.
This dissertation research will illustrate three synthetic strategies towards the total synthesis of
ascaulitoxin aglycone from chiral pool building blocks. Strategy 1 invokes the use of the Henry
reaction as a key step for the construction of the central C4-C5 cis-aminohydroxy group, which
was moderately successful, but abandoned in favor of olefination protocols. Strategy 2 invoked
the Wittig reaction as a key reaction for the formation of a C4-C5 olefin, but was also abandoned
due to lack of reactivity of an unstabilized ylide with an advanced aldehyde coupling partner.
The key C4-C5 olefin was successfully installed by using a Grubbs olefin metathesis reaction of
benzyl protected D-allylglycine (homodimerization) with 2ndgeneration catalysts in the presence
of copper iodide. Subsequent asymmetric Sharpless aminohydroxylation of the precursor olefin
substrate resulted in creation of the key C4-C5 aminohydroxy unit, with requisite synstereochemistry and formation of inseparable diastereomers. Catalytic hydrogenation and
transfer catalytic hydrogenation reactions using Pd catalysts were employed for the complete
deprotection of three N-CBz and two carboxybenzyl groups towards target ascaulitoxin
aglycone, but were met with limited success due to potential catalyst poisoning events.
ii

DEDICATION

This work is dedicated to my family, who has provided me with undying love and support.

iii

ACKNOWLEDGMENTS

I would like to thank Dr. John M. Rimoldi, for adopting me into his research group. I
would also like to thank him for his constant mentorship, encouragement, and for believing in
my abilities as a scientist. Dr. Rimoldi’s passion and enthusiasm for both teaching and research
has truly inspired me to strive for excellence in both arenas. Dr. Rimoldi has made a profound
impact on my life as a mentor and friend. Moving forward in my career I hope to be as
accomplished of a scientist, leader, and advisor as Dr. Rimoldi has been for his research group.
I would also like to thank Dr. Rama Sarma Gadepalli for his outstanding guidance over
the years. He has always been willing to sacrifice his time to help train students in organic
synthesis, myself included. I have been extremely fortunate to work alongside of someone as
knowledgeable and helpful as Dr. Gadepalli. I would also like to thank everyone that I have had
the benefit of working with over the years in the Rimoldi lab, your help and friendship as truly
made graduate school enjoyable. To Dr. Braga, Dr. Smith, Dr. Scarry, Kimberly, Zarana, Eric,
and Mike – Thank you guys so much!

iv

TABLE OF CONTENTS

CHAPTER

PAGE

ABSTRACT........................................................................................................................ ii
DEDICATION ................................................................................................................... iii
ACKNOWLEGMENTS .................................................................................................... iv
LIST OF FIGURES .......................................................................................................... vii
LIST OF SCHEMES.......................................................................................................... ix
LIST OF TABLES ............................................................................................................. xi
I. BACKGROUND INFORMATION .................................................................................1
1.1 Herbicide Resistance…………………………………………………………………..1
1.2 Mechanisms of Action of Known Herbicides…………………………………………5
1.3 Natural Product Herbicides…………………………………………………………..12
1.4 Commercially Available Natural Product Herbicides………………………………..14
1.5 Natural Product Herbicides with Mechanisms of Action That Are Not Employed
Commercially……………………………………………………………………………..17
1.6 The Natural Product Herbicide Ascaulitoxin Aglycone……………………………...19
II. SYNTHETIC APPROACHES TOWARDS THE NATURAL PRODUCT ASCAULITOXIN
AGLYCONE……………………………………………………………………..23
2.1 Synthetic Strategy 1: The Henry Reaction as a Key Step…………………………….23
v

2.2 C-C Coupling Reaction: Nitroaldol (Henry) Reaction……………………………….30
2.3 Wittig Approach...........................................................................................................35
2.4 Synthetic Approach Utilizing the Wittig Reaction…………………………………...35
2.5 Synthetic Route: Wittig Reaction…………………………………………………….37
2.6 Exploring the Wittig Reaction………………………………………………………..40
2.7 Grubbs Approach .........................................................................................................42
2.8 Synthetic Rational for Utilizing Olefin Cross Metathesis……………………………42
2.9 Synthetic Approach Utilizing Olefin Cross Metathesis………………………………45
2.10 Sharpless Asymmetric Aminohydroxylation………………………………………..49
2.11 Carboxybenzyl and N-Cbz Deprotection…………..……………………………….54
2.12 Conclusion…………………………………………………………………………..55
2.13 Future Work………………………………..………………………………………..57
EXPERIMENTAL .............................................................................................................58
BIBLIOGRAPHY ..............................................................................................................82
APPENDIX…. ...................................................................................................................92
VITA ................................................................................................................................119

vi

LIST OF FIGURES

FIGURE

PAGE

1.1 Global Increase in Unique Herbicide Resistance Weed Cases ......................................3
1.2 Increase in Unique Herbicide Resistance Weed Cases in thee USA .............................4
1.3 Commercially Available Herbicides I ...........................................................................6
1.4 Commercially Available Herbicides II ........................................................................10
1.5 Commercially Available Herbicides III .......................................................................12
1.6 The Composition of Herbicide Market ........................................................................14
1.7 Natural Product Derived Commercial Available Herbicides.......................................15
1.8 Natural Products with a Novel Mechanism of Action .................................................19
1.9 Natural Products from Ascochyta caulina ..................................................................21
2.1 Dose Response to ascaulitoxin aglycone treatment .....................................................21
2.1 Effects of amino acid supplementation ........................................................................22
2.1 Ascaulitoxin aglycone effect on aminotransfersae activity .........................................23
2.1 Ascaulitoxin aglycone ..................................................................................................24
2.2 Retro-Synthesis I..........................................................................................................25
2.3 Pharmaceuticals that Utilize the Henry Reaction ........................................................32
2.4 Retro-Synthesis II ........................................................................................................36
vii

2.5 Ruthenium Catalysts ....................................................................................................43
2.6 Olefin Categorization and Rules for Selectivity ..........................................................44
2.7 Attempts at the Grubbs Coupling ................................................................................48
2.8 Mechanism of Aminohydroxylation ............................................................................49
2.9 Elimination of Regiochemistry ....................................................................................50

viii

LIST OF SCHEMES

Scheme

PAGE

1. Synthesis of Homoserine Derivatives ............................................................................26
2. Synthesis Henry Coupling Partners ...............................................................................27
3. Synthesis of Bromoalkane ............................................................................................28
4. Synthesis of Nitroalkane ................................................................................................29
5. Synthesis of Henry Aldehyde ........................................................................................30
6. Henry Reaction ..............................................................................................................31
7. Testing the Henry Reaction ...........................................................................................33
8. Nitroalcohol Synthesis ...................................................................................................34
9. Wittig Reaction ..............................................................................................................36
10. Synthesis of Key Bromoalkane Analog .......................................................................37
11. Attempt at the Synthesis of Phosphonium Salt ............................................................38
12. Formation of Elimination Product ...............................................................................38
13. Synthesis of Wittig Aldehyde ......................................................................................39
14. Synthesis of Wittig Alkene ..........................................................................................41
15. Cross Metathesis ..........................................................................................................43
16. Retro-Synthesis III .......................................................................................................45
17. Synthesis of Grubbs Alkene.........................................................................................46
ix

18. Aminohydroxylation ....................................................................................................51
19. Esterification of Aminohydroxylation Products ..........................................................52
20. Improved Synthesis of Aminoalcohol .........................................................................53

x

LIST OF TABLES

Tables ......................................................................................................................... PAGE
1.1 Advantages/Limitations of a Natural Product Approach .............................................13
2.1 Attempts at Catalytic Deprotection ..............................................................................54

xi

CHAPTER I
BACKGROUND INFORMATION

Since the dawn of agriculture people have had to cultivate and maintain farmland to
ensure a plentiful harvest. The techniques we use today differ dramatically from our early
ancestors. Today we have the benefit of chemical herbicides to aid in the battle against nuisance
weed species and their attack on farmland. Synthetic herbicides were introduced in the 1940s and
since their induction they have proven to be the primary tool for weed management.1 Herbicides
historically have proven to be highly effective, cost efficient, and relatively easy to use,1 factors
that continue to make herbicides highly desirable. This is evident in the value of the herbicide
market; in 2007 the United States market grossed $7.9 billion annually, up from the $7.1 billion
grossed in 1980.2 The herbicide market grossed approximately $17 billion dollars globally in
2010.3
1.1 Herbicide Resistance
As a result of the continued use of herbicides, their effectiveness has diminished precipitously.
The continued use of the same herbicide or ones with similar modes of action results in weed
populations that have developed mechanisms of resistance. Resistance was first recognized as a
serious issue as early as 1968 when it was discovered that a common groundsel (Senecio vulagris
L.) population was no longer responsive to atrazine.1, 4 The real problem of herbicide resistance
became increasingly evident to the weed science community in the 15 year period between 19801

1995.1 The cases of herbicide resistances rose five-fold from the 41 reported in 1980 to the 191
reported in 1995.1 Resistance mechanisms can be divided into two types: target-site resistance
and non-target-site resistance.5 Target-site resistance is characterized as a mutation or mutations
to an enzyme that confers enzymatic insensitivity toward herbicides.5 Non-target site resistance
is defined as a change that allows a plant to prevent herbicides from reaching their enzymatic
target site. This is usually accomplished by preventing uptake or transport of a herbicide
invoking resistance to that herbicide.5 In 1996, glyphosate-resistant crops were introduced
commercially to North and South America.1 Glyphosate resistant crops are genetically modified
crops that lack the enzymatic activity toward glyphosate. This radically changed the landscape of
weed management in corn, cotton, and soybean farming.1 This is evident when comparing
herbicides used from 1995 to 2004. In 1995, there were six to nine herbicides with different
mechanisms of action used on certain corps, however by 2004 that number had dropped to one.1
Glyphosate was the single herbicide used due to its broad spectrum of activity, reliability of use,
and cost effectiveness.1 The overuse of glyphosate, as one may predict, resulted in developed
resistance in the U.S. being reported as early as 2000. By 2005, glyphosate resistant weeds had
become a serious issue with horseweed, Palmer amaranth, waterhemp, and giant ragweed
populations.6 The problems continued to worsen, and as of 2013, there was over 400 unique
cases of weed resistance reported globally that represented 22 of the 25 known herbicide
mechanisms of action, see Figure 1.1.6
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Figure 1.1

While the picture is not as bleak in the U.S., the problem is still very apparent with over 140
unique case of resistance reported as of 2013, see Figure 1.2.6

3

Figure 1.2

As the problem of herbicide resistance grows, farmers will be faced with the challenge of trying
to overcome significant crop loss. Weed scientists continue to educate farmers to aid in the fight
against herbicide resistance by teaching them techniques that incorporate both chemical and nonchemicals approaches. It is evident that not only new approaches need to be taken, but also
researchers need to continue the search for new herbicides that possess novel mechanisms of
action.

4

1.2 Mechanisms of Action of Known Herbicides
It would be remiss to omit a brief review of the mechanisms of action currently being
utilized by commercial herbicides. Herbicides can be extremely fast acting (paraquat) or slow
acting in eliciting their effects (glyphosate), largely dependent on the molecular target affected.7
Synergism can exist between different herbicides minimizing the probability of weeds
developing resistance. This reduced probability to resistance stems from the plant’s inability to
overcome two different selective pressures. Unfortunately, most farms have extensively used
single herbicides over a long period of time allowing some weed species to develop resistance.
Understanding a herbicide’s mechanism of action can also aid in the understanding of the
mechanism of resistance because in some cases, resistance is based on a slight change to the
herbicide’s molecular target site.8
Some of the first synthetic herbicides to be commercialized were the photosynthesis
inhibitors, specifically photosystem II inhibitors. Photosystem II is required for the first step of
photosynthesis to split water into molecular oxygen. There are more than 40 marketed
photosystem II inhibitors made up of several different chemotypes, the ureas (diuron), triazines
(atrazine), amides (propanil) and hydroxybenzonitriles (bromoxynil), see Figure 1.3.9 There has
been resistance reported for most all the photosystem II inhibitors, and in the case of triazines
there are over 60 weed species that have demonstrated resistance. In most cases, resistance it is
due to an active site mutation within photosystem II that reduces binding of these herbicides.7

5

Figure 1.3

Photosystem I has a primary responsibility in photosynthesis to provide the reducing power to
convert NADP into NADPH. Photosystem I inhibitors include paraquat and diquat, see Figure
6

1.3.9, 10 These inhibitors have immediate effects in plants demonstrating wilting followed by
necrosis within one hour. Resistance to photosystem I inhibitors has also been detected with
over 21 different species developing resistance, displayed through up-regulation of superoxide
dismutase, which allows for oxidative rescue from over- production of superoxide species.7
Some herbicides disrupt plant function by interfering with plant pigment synthesis.
Phytoene desaturase is a critical enzyme required for the production of carotenoids. Carotenoids
help stabilize chloroplast membranes and quench reactive oxygen species. Plants lacking
carotenoids cannot accumulate chlorophyll and therefore cannot undergo photosynthesis.11 There
are several inhibitors of this enzyme, including norflurazon, fluridone, and flurtamone .12 There
are very few weed species that have developed resistance to these herbicides due to the
requirement of more than one amino acid change in the target site to abolish activity.7
Deoxyxylulose-5-phosphate synthase (DPS) is another key enzyme involved in the
terpenoid pathway for the formation of carotenoids. Inhibition of the enzyme elicits the same
effect as inhibiting phytoene desaturase. Clomazone is the only inhibitor of this enzyme and is
considered a proherbicide. It requires metabolic activation to 5-ketoclomazone to inhibit
deoxyxylulose-5-phosphate synthase. The only resistance seen to this herbicide appears to be due
to enhanced metabolic degradation.7
The enzyme hydroxyphenylpyruvate dioxygenase (HPPD) is essential for the production
of plastoquinone. Plastoquinone is cofactor for phytoene desaturase, therefore HPPD inhibitors
elicit the same response in plants as DPS inhibitors.13 HPPD inhibitors comprise three classes:
the triketones (mesotrione), the isoxazones (isoxaflutole), and the benzoylpyrazoles
(pyrazolynate), see Figure 1.3.7 There is no known resistance reported to these classes of
herbicides. This mechanism of action was the last molecular target site introduced to the market,
7

over 20 years ago.13
Protoporphyrinogen IX oxidase (Protox) is an enzyme required for porphyrin synthesis.
Porphyrins are required for both chlorophyll and heme synthesis. The inhibition of Protox results
in weed burning and immediate necrosis of the host plant.14 There are several chemical classes
that possess activity including the diphenyl ethers (acifluorfen), oxadiazoles (oxdiazon), and
triazolinones (sulfentrazone). There are only five weed species that have been reported to exhibit
resistance to Protox inhibitors.7
Other mechanisms of action involve impeding the formation of critical plant building
blocks. There are compounds that inhibit the incorporation of glucose into cellulose. Two
registered compounds are isoxaben 1.17 and dichlobenil 1.18, see Figure 1.4. Isoxaben
attenuates the conversion of sucrose into UDP-glucose, while dichlobenil inhibits cellulose
synthase enzyme complex.15 No resistance has been reported for these herbicides.
Lipid synthesis inhibitors inhibit one of two enzymes, either acetyl-coenzyme A
carboxylase (ACCase) or very-long-chain fatty acid (VLCFA) elongases. ACCase is a key
enzyme that catalyzes the very first step in fatty acid synthesis; therefore inhibition of ACCase
depletes the plant of fatty acids necessary for plant homeostasis.16 There are two predominate
classes of ACCase inhibitors, the cyclohexanediones (sethoxydim) 1.19 and
aryloxyphenoxypropionates (diclofop-methyl) 1.20, see Figure 1.4.7 There are approximately 40
grass species that have developed resistance to ACCase inhibitors. Resistance is seen both
through active site mutation as well as metabolic degradation.
Very long chain fatty acids (VLCFAs) are necessary for normal cell function because
they are used as building blocks to make wax responsible for keeping moisture inside a plant
cell. A reduction in VLCFAs in the cell membrane leads to cell division and growth. Inhibition
8

of VLCFA elongases results in decreased growth, leaf curling and leaf twisting. Inhibitors of this
enzyme include chloroacetanilides (alachlor) 1.21, tetrazolinone (fentrazamide) 1.22, and
oxyacetamides (flufenacet) 1.23, see Figure 1.4.7 There are only a few weed species that display
resistance these herbicides and the mechanism of resistance is not currently known.
Other mechanisms used by commercial herbicides are those that inhibit the synthesis of
key amino acids. The most notorious of all herbicides is glyphosate, see Figure 1.4. Glyphosate
1.24 is the most widely used herbicide both in volume and land area treated. This is due to the
widespread use of transgenic crops that are resistant to glyphosate. Glyphosate inhibits 5enolpyruvylshikimate-3-phosphate (EPSP) synthase, which is an enzyme involved in the
biosynthesis of aromatic amino acids.17 Glyphosate resistance has been reported and there are
now a number of weed species that possess glyphosate resistance.
Acetolactate synthase is an enzyme that is involved in the biosynthesis of three branched
chain amino acids leucine, isoleucine, and valine. Acetolactate synthase inhibitors represent the
largest group of commercial herbicides. Inhibitors of this enzyme are made up several chemical
classes including sulfonylureas (chlorsulfuron) 1.25, imidazolinones (imazapyr) 1.26, and
pyrimidyl(thio)benzoates (pyrithiobac) 1.27, see Figure 1.4.18
Glufosinate 1.28 is the only glutamine synthetase inhibitors and broad-spectrum
herbicide. It is commercial sold as a racemic mixture and has a natural product counterpart
phosphinothricin. This class of herbicides will be covered more extensively in section 1.3.
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Figure 1.4
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There are several classes of structurally diverse compounds that inhibit tubulin formation
such as the dinitroanilines (trifluralin) 1.29 and substituted amides (dithiopyr) 1.30, see Figure
1.4.10 Tubulin exists as - and -tubulin subunits, which assemble into bundles to form
microtubules. Microtubules are involved in cell division, elongation, and cell wall formation.
There are approximately 10 weed species that have gained resistance to these herbicides due to
enhanced metabolic degradation.9
Some of the earliest synthetic herbicides were developed to mimic auxin (indole acetic
acid). Auxin is a plant hormone that regulates cell elongation and growth, among other process.
Chemical classes used commercially include phenoxycarboxylic acids (2,4-D) 1.31 and benzoic
acid (dicamba) 1.32, see Figure 1.5.15 There at least 30 weed species that have developed
resistance to auxin mimics worldwide with their mechanism of resistance not clearly understood.
Auxin is essential for proper growth and development but must transported to sites within the
plant to elicit its effect. Auxin transport inhibitors represent another mechanism of action utilized
by commercial herbicides. There are two herbicides that inhibit auxin transport, diflufenzopyr
1.33 and naptalam 1.34, see Figure 1.5. There is no current resistance reported for these
herbicides.19
7,8-dihydropteroate synthase is required for folic acid synthesis. Asulam 1.35 is the only
inhibitor of 7,8-dihydropteroate synthase. There is no reported cases of resistance to asulam.7
Protein phosphatases are important for many cellular processes in plants. Inhibition of
protein phosphatases causes cellular dysfunction leading to cell death. Endothall 1.36 is the only
herbicide that acts on this enzyme.
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Figure 1.5

With resistance being found in the majority of commercial herbicides it is necessary to continue
to explore compounds with novel mechanisms of action. This can be accomplished using a
natural product approach: increasing the changes of structural diversity among chemical classes
thereby increasing the likelihood of identifying molecular targets by probing nature’s own
chemical defenses.
1.3 Natural Product Herbicides
As weeds continue to acquire resistance to commercially used herbicides, the
mechanisms by which they act become less effective, depleting entire classes of herbicides of
their utility. In the past 20 years there has not been a new herbicide commercialized which
possessed a novel mechanism of action.20 This pattern has led to the real issue facing weed
management today with over 80% of the current marketed modes of action exhibiting cases of
reported resistance. This problem has led to a decrease in crop production as well as an increase
in cost of weed management. To reverse these trends, the discovery and development of new
12

herbicides with novel modes of action are warranted.
A natural product approach will aid in overcoming resistance issues while bolstering new
herbicide discovery and development. Natural products have proven to be a great source for new
chemical diversity. With modern advances in high-throughput screening and compound
identification technology, discovery of bioactive natural products can be fairly rapid. Also, since
most natural products are structurally complex secondary metabolites, this should improve the
likelihood that some possess biological activity against other organisms.21 There are limitations
to a natural products approach. The natural source maybe hard to obtain, structures may be too
costly or too complex for chemical synthesis, and natural products themselves could be too toxic
for use.20 Table 1.1 provides a summary of the advantages and limitation to a natural product
approach.

Table 1.1
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Natural products have proven their utility in human health with 80 % of marketed
pharmaceutical drugs represented by natural products or natural product-derived compounds.20
In fact, natural products herbicides are largely underrepresented when one considers
conventional herbicides use, see Figure 1.6.22

Figure 1.6

Considering the success that the pharmaceutical industry has had in the discovery of unique
chemical structures that possess biological activity through novel mechanisms, the same
argument can be made for the weed management industry.
1.4 Commercially Available Natural Product Herbicides
Phosphinothricin 1.37 and bialaphos (the tripeptide analog) are post-emergent herbicides that
14

possess a broad spectrum of activity controlling a wide range of weeds, see Figure 1.7.23
Bialaphos is marketed in Asia and is obtained from an actinomycete Streptomyces hygroscopis.24
It is also considered a proherbicide because it requires bioactivation into L-phosphinothricin to
exhibit its effect.20 In the U.S. glufosinate 1.38, the synthetic form of L-phosphinothricin, is
produced and used.25 What is equally striking about glufosinate is that it represents a new class
of herbicides, its mechanism of action involves the direct inhibition of glutamate synthetase.20
Another class of structurally diverse natural product herbicides are the triketone herbicides, see
Figure 1.7.

Figure 1.7
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The triketone class is the last class of natural product herbicides to be registered with the EPA
since 1997.22 Bioassay-guided isolation work led to the discovery of leptospermone 1.39.26
Leptospermone was observed to cause bleaching in plant tissue of the bottlebrush plant
(Callistemon citrinus).26 Leptospermone herbicidal activity was synthetically modified and
eventually led to commercial herbicides like sulcotrione 1.40, Figure 1.7.20 After probing the
mechanism of action, it was found that the triketone class inhibits p-hydroxyphenylpyruvate
dioxygenase (HPPD).27 HPPD is the enzyme that catalyzes the formation of homogentisate, one
of the first steps in tyrosine catabolism.22 Cantharidin 1.41 represents another potent natural
product herbicide that possesses a unique mode of action. Cantharidin is produced by the both
the blister beetle and the Spanish fly as a potent toxin for chemical defense.28 Cantharidin and
cantharadic acid derivatives such as the commercial herbicide endothall 1.36 are inhibitors of
serine/threonine protein phosphatases.28 By inhibiting multiple phosphatases, it is unlikely for
weeds to develop resistance to this class of herbicides. Cineole herbicides 1.42 are an additional
class of natural product herbicides isolated from aromatic plants. These cineoles are symmetrical
monoterpenes and are present in essential oils. They are phytotoxic, which inspired the
development of synthetic analogs to help optimize this activity. The analogs contain a 1,4cineole backbone with an additional benzyl ether functionality to aid in reducing their
volatility.29 This is evident in the structural features of the commercial herbicide cinemethylin
1.43, see Figure 1.7. The mechanism of this class is unknown, however data suggests that they
may be tyrosine aminotransferase inhibitors.30 These compounds represent natural products that
are currently on the market or are natural product derived and commercially available.
1.5 Natural Product Herbicides with Mechanisms of Action That Are Not Employed
Commercially
16

When one considers sources to explore for the potential to yield phytotoxins, an obvious source
is soil microorganisms with the commercially used herbicides bialaphos and glufosinate as prime
examples.20 Soil microorganisms are a rich source of new chemical diversity among herbicide
classes. The ability to ferment microorganisms on a large-scale to obtain phytotoxins in
sufficient quantities also makes them an attractive source.20 In this section a number of natural
products obtained from microorganisms that possess herbicidal activity through a mechanism
that is not currently marketed will be described. Thaxtomin A 1.44 is produced by Streptomyces
scabies, and is a phytotoxic cyclic dipeptide that causes scab disease in potato. Thaxtomin A
elicits its phytotoxic effects by inhibiting cellulose synthesis, and its herbicidal activity has been
patented but not yet marketed.31 Actinonin 1.45 is produced by soil actinomycetes. Structurally it
is a hydroxamic acid pseudopeptide and exhibits its biological activity through inhibition of
peptide deformylase. Inhibiting peptide defomylase eliminates protein translation in prokaryotes
by not removing the N-formyl group from N-formyl methionine.32 Another natural product that is
found in numerous Strepomyces strains is hydantocidin. Hydantocidin is considered to be a
proherbicide since it requires enzymatic phosphorylation before it can inhibit adenylosuccinate
synthetase, an enzyme involved in purine biosynthesis.33 Hydrantocidin 1.46 was heavily
pursued for its herbicidal activity; however efforts were eventually abandoned due to cost of its
complex synthesis.20 Tentoxin 1.47 is an additional natural product from Alternaria alternate. It
is a cyclic tetrapeptide that causes extreme chlorosis of the foliage by inhibiting chloroplast
ATPase.34 Another natural product that possesses herbicidal activity that is not commercially
available and is perceived to possess a novel mechanism of action is ascaulitoxin aglycone
1.48.35

17

Figure 1.8
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Another rich source for natural product phytotoxins are plants themselves. It should not
be a surprise that plants would produce phytotoxins as a chemical defense mechanism against
other plants. In section 1.4 we discussed both triketones and cineoles that are both isolated from
plant sources. Benzoxazinoids are found in the roots of a number of grass species and possess an
array of biological activities, including herbicidal. Benzoxazinoids like benzoxazoline 1.49
persist in soil and it has been demonstrated that the soil degradation products of benzoxazoline
may be responsible for the herbicidal activity of this class of compounds.36 The mechanism of
action for the benzoxazinoids class is not clearly understood. Sarmentine 1.50 is another example
of a natural product herbicide isolated from the fruit of the long pepper (Piper logum L.) which is
known to disrupt the plant cuticle, leading to cell membrane damage and ultimately death.37
Citral 1.51 is a diterpene found in the essential oils of many plants but most notably lemongrass.
In high concentrations it can cause burndown of weeds. Citral disrupts microtubule
polymerization.38 These examples of natural product herbicides that have non-commercialized
mechanisms of action is just a small sampling of the underutilized potential natural products
could have for the future of weed management.
1.6 The Natural Product Herbicide Ascaulitoxin Aglycone
Ascaulitoxin 1.52, is a bis-amino acid N-glucoside isolated from the fungal species
Ascochyta caulina.39 Ascaulitoxin exhibited herbicidal activity against Chenopodium album, also
known as lambsquarter, a common weed globally.39 Upon closer investigation Ascochyta caulina
extracts contained three compounds that all possess herbicidal activity, ascaulitoxin 1.52, trans4-amino-D-proline 1.53, ascaulitoxin aglycone 1.48, with ascaulitoxin aglycone exhibiting the
most potent activity, see Figure 1.9.35, 40
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Figure 1.9

Duke and his team of researchers at the USDA ARS unit in Oxford MS investigated the
mechanism of action of the most potent of these three compounds, ascaulitoxin aglycone.35
Ascaulitoxin aglycone is a potent mycoherbicide exhibiting an I50 below 1 M against Lemna
paucicostata, see Figure 1.10.35 Ascaulitoxin aglycone acts slowly, attenuating growth and
eventually causing chlorosis and death.20

Figure 1.10
Ascaulitoxin activity was found to be reversed by amino acid supplementation of several amino
20

acids including lysine but others like glutamine had no effect, see Figure 1.11.35

Figure 1.11
It was determined that inhibition of amino acid synthesis was not the mechanism of action since
the activity was not reversed with D- amino acids.20 A metabolomic approach revealed that
ascaulitoxin aglycone causes changes in amino acids; this activity is usually associated with
inhibition of aminotransferase, however it exhibited no activity against the aminotransferases
21

tested, see Figure 1.12.20, 35

Figure 1.12
This observation lead researchers to conclude that ascaulitoxin aglycone appears to possess a
novel mechanism of action.20 Ascaulitoxin aglycone’s potent activity and possible novel
mechanism of action makes a perfect candidate for further study in pursuit of new natural
product herbicides. This dissertation research will outline three approaches investigated towards
the total synthesis of ascaulitoxin aglycone

22

CHAPTER II:
SYNTHETIC APPROACHES TOWARDS THE NATURAL PRODUCT ASCAULITOXIN
AGLYCONE

Natural products provide a rich source of secondary metabolite structural diversity
allowing researchers to cover more chemical space while screening for new leads. Natural
products not only serve as the starting point for many new drugs they also play important roles as
molecular probes for investigating critical biological processes. It is for these reasons that the
demands for new natural product lead compounds remain high. Unfortunately, natural products
are sometimes overlooked or avoided due to the perception of limited supply or synthetic
complexity. The future of natural products should be to address these issues at their core by
taking approaches that generate new synthetic methodologies or strategies that yield sufficient
material for further development.41
2.1 Synthetic Strategy 1: The Henry Reaction as a Key Step
Our interest in ascaulitoxin aglycone is not only embedded in its herbicidal activity but
also in its deceivingly complex synthesis. Ascaulitoxin aglycone, (2R,4S,5S,7R)-2,4,7-triamino5-hydroxyoctanedioic acid, is a bis-amino acid that contains four stereogenic centers, as shown
in Figure 2.1.
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Figure 2.1 Ascaulitoxin aglycone
Additional structural features that add to its synthetic complexity are the cis amino hydroxy
substituents at C4-C5 and that it consists of unnatural (D)-alpha-amino acids.
Our initial retro-synthetic approach began with a disconnection between C-4 and C-5, as
highlighted in Figure 2.2.

Figure 2.2 Retro-synthesis
The disconnection between C-4 and C-5 yield key synthons nitroalkane 2.2 and aldehyde 2.3.
The assembly of these two synthons using a nitro-Aldol reaction, or most commonly referred to
as a Henry reaction will afford target compound 2.1. Both the nitroalkane 2.2 and aldehyde 2.3
can be derived from homoserine 2.4. Homoserine can be synthesized from the readily available
pool amino acid methionine (2.5). Although the natural product consists of unnatural D-amino
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acid groups, it was necessary to rehearse the viability of the Henry reaction utilizing D-amino
acid starting materials due to cost limitations. In the event the chemistry was successful,
reactions were repeated with D-amino acids.
Initiating the synthetic protocols using a chiral pool amino acid dramatically reduces the
complexity of the synthetic strategy by reducing the number of possible diastereomers. The
synthesis started with conversion of L- methionine to L- homoserine, see Scheme 1.

Scheme 1a

L-Methionine

was initially methylated with iodomethane to afford the dimethyl sulfonium salt

2.6. An SN2 displacement of dimethyl sulfide to the primary alcohol afforded an equilibrium
mixture of homoserine 2.4 and its corresponding lactone 2.7, respectively. The mechanism for
homoserine generation from the dimethyl sulfonium salt 2.6 required a free carboxylic acid. As
base is added to the reaction, the acid is deprotonated allowing the carboxylate anion to attack
the C-4 carbon yielding the cyclized -lactone. This was deduced experimentally; when the
25

corresponding methyl ester of 2.6 was reacted under identical conditions, homoserine or its
corresponding lactone was produced. Lactone 2.7 is the stable form of homoserine 2.4, and
can be hydrolyzed to the desired homoserine. This reaction is highly pH sensitive and requires
careful addition of base over a 12 h period. In solution homoserine and the corresponding lactone
exist in equilibrium with the equilibrium shifted toward lactone under acidic condition and
favoring homoserine under basic conditions.42 The yields for this reaction were low due to this
equilibrium.
With 2.4 in hand we began devising an efficient but useful protecting group strategy. As
illustrated in in Scheme 1 multiple “benzyl” protecting groups were selected; the amine group of
2.4 was reacted with benzyl chloroformate yielding 2.8 followed by benzylation of the
carboxylic acid to generate protected homoserine 2.9. Additionally, methyl ester 2.10 was
synthesized using iodomethane as the electrophile. This benzylation strategy was adopted since
it allowed for a mild deprotection protocol (catalytic hydrogenation) without invoking acid/base
protocols. It was important to avoid strong acid/base conditions in the deprotection strategy,
especially late in the synthetic route, because of the forecasted lactonization chemistry occurring.
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Scheme 2a

After effectively installing the protecting groups to yield 2.9, this key intermediate allowed for
the production of two separate coupling partners for the Henry reaction. The first coupling
partner was synthesized from the oxidation of alcohol 2.9 to the corresponding aldehyde 2.11.
using a Dess-Martin oxidation. The diagnostic resonance at 9.71 ppm in the 1H NMR spectrum
confirmed the presence of an aldehyde group in compound 2.11. The other required synthon 2.13
was synthesized through a two-step sequence from key intermediate 2.9. Treatment of 2.9 with
triphenylphosphine and imidazole followed by reaction with sodium iodide yielded iodide 2.12.
Iodoalkane 2.12 was subsequently treated with sodium nitrite to afford nitroalkane 2.13. The
structure of nitroalkane 2.13 was verified by mass spectral data in addition to the presence of the
diagnostic triplet at 3.4 ppm in the 1H-NMR spectrum. Although, both coupling partners were
successfully synthesized utilizing this strategy diminished yields were continually observed due
to the undesired lactonization chemistry between 2.4/2.7 and 2.9/2.14. The ease of lactonization
dramatically hampered efforts to move forward with a sufficient quantity of material required to
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explore the Henry reaction.

Scheme 3a

We revised the synthetic route to take advantage of the homoserine -lactonization chemistry. In
the revised approach the synthesis of the nitroalkane coupling partner was modified to utilize a
lactone intermediate, and the synthesis of the aldehyde coupling partner was modified to reduce
lactonization using a dimethyl hydroxylamine intermediate. The revised pathway began with the
reaction of L- methionine with bromoacetic acid to promote cyclization to the lactone
intermediate 2.15 as shown in Scheme 3. The hydrobromide lactone salt was then subjected to
reaction with hydrobromic acid in glacial acetic acid to afford the brominated derivative 2.16.
The completion of this reaction was apparent by monitoring the reaction using LC-MS; the
bromine isotope pattern confirmed the success of the reaction. Next, methylation of the
carboxylic acid with thionyl chloride and methanol yielded methyl ester 2.17, followed by N-Cbz
protection of the amine to yield protected analog 2.18, see Scheme 3.
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Scheme 4a

Although bromoalkane 2.18 can be directly converted to the nitroalkane 2.20, the reaction was
faster and yields were enhanced when 2.18 was converted initially to the more reactive
iodoalkane 2.19, see Scheme 4.
Scheme 5a

With one coupling partner (nitroalkane 2.20) successfully synthesized, the modified protocol for
the aldehyde coupling partner was investigated. Lactone 2.15 served as a useful intermediate,
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insofar as N-Cbz protection to 2.21, followed by reaction with dimethylhydroxylamine resulting
in the production of protected analog 2.22. The utility of dimethylhydroxylamine protection
satisfied two requirements. First, a base was required to hydrolyze the lactone, and second, the
carboxylic acid functionality demanded protection with a functional group that demonstrated
reduced lactonization potential. The subsequent amide 2.22 can also be readily converted back to
the carboxylic acid with aqueous hydroxide at room temperature.43 The structure of 2.22 was
verified by evaluation of the 1H-NMR resonances at 3.2 and 3.8 ppm, corresponding to the two
methyl signals of dimethylhydroxylamine. Compound 2.22 was subjected to a Dess-Martin
oxidation to obtain aldehyde 2.23, without products contaminated with lactone side products, see
Scheme 5.

2.2 C-C Coupling Reaction: Nitroaldol (Henry) Reaction
Simple nitroalkanes have long been utilized in organic synthesis for their ability to undergo
various carbon-carbon bond formation reactions. One of the most notable of these reactions is
the nitroaldol or Henry reaction.. The Henry reaction, first discovered in 1895, employs the use
of a nitroalkane and a base to yield an intermediate carbon nucleophile that can be reacted with a
aldehyde counterpart, see Scheme 6.44
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Scheme 6

One of the major drawbacks to using the Henry reaction lies in the lack of stereogenic control
and the production of diastereomers; recent advances in the field has addressed these issues and
the asymmetric Henry reaction continues to grow in both scope and utility.45, 46 The asymmetric
Henry reaction is also very useful since it generates chiral nitroalcohols that are important in the
synthesis of both natural and synthetic molecules.47 Since the first report of an asymmetric Henry
reaction by Sassi et al. in 1991, the utility of the reaction has continue to grow.48 Taxol, is a very
well known anticancer agent isolated from Taxus brevifolia.49. However, the major drawbacks of
taxol production are its limited availability from natural sources and the complexity of its total
synthesis.49 Borah et al. were able to reduce the complexity by employing an asymmetric Henry
reaction to complete taxol’s C-13 side chain in a 33% overall yield, see Figure 2.3.44, 49 The
Henry reaction is also important in the synthesis of other important pharmaceuticals including
the -blocker (S)-propranolol, the HIV protease inhibitor amprenavir, and in the carbohydrate
subunit of the antibiotic class anthracycline, L- acosamine.48
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Figure 2.3
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Scheme 7a

In our efforts to explore the Henry reaction as a key reaction model rehearsal reactions
were initially evaluated to probe optimal reaction conditions. Although the Henry reaction has
been exhaustively investigated using simple nitroalkanes (nitromethane, nitroethane) and simple
aldehydes, reported reactions invoking complex coupling partners are scant. Due to these
reasons, model reactions were conducted using simple aliphatic and aromatic aldehydes as
coupling partners to explore the viability of the Henry reaction. Initial attempts using
benzaldehyde in the Henry reaction with 2.20 revealed that aromatic aldehydes were not
acceptable coupling partners (no reaction products identified) and that small aliphatic aldehydes
reacted modestly when potassium phosphate was employed as a base. Other bases used in the
model reactions failed to produce nitroalcohol products, or yields were dramatically reduced.
Diastereomeric selectively of the reaction was not a concern at this juncture, since additional
diastereomers generated from the Henry reaction could be isolated and characterized, and used to
explore the structure-activity relationship concerning herbicidal activity. With the Henry reaction
33

optimized for base, the reaction of 2.20 and 2.23 was performed repeatedly. To our dismay the
reaction was less than desirable affording disappointing yields and variable reproducibility, see
Scheme 8.

Scheme 8a

The Henry reaction was repeated numerous times and experimental conditions were altered with
respect to reaction time, solvent, and choice of base. Scheme 8 represents the optimal conditions
and best yield achieved. Although the Henry reaction represented a reasonable key step in the
synthesis of ascaulitoxin aglycone, it presented a substantial challenge. A thorough review of the
literature revealed that the Henry reaction tolerates small nitroalkanes or small aldehydes as a
coupling partner to their larger counterpart.45-47, 50, 51 The literature is largely absent with respect
to successful examples of Henry reactions when both coupling partners are complex. In these
instances, competing reactions including retro-aldol and elimination reactions are possible. This
synthetic protocol was abandoned in favor of protocols comprising the C4-C5 cis-aminohydroxy
group installation from olefin precursors.
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2.3 The Wittig Approach
As it became apparent that the original synthetic approach using the Henry reaction as the
key carbon-carbon bond forming reaction would not be suitable alternate syntheses were
explored. Initial attempts were made to salvage the more salient aspects of the chemistry
previously explored using the Henry reaction approach. Reaction types that utilized nucleophilic
addition to a carbonyl or carboxylic acid via a nucleophilic carbon were considered. There are
several classical carbon-carbon bond forming reactions that fit this criterion and include but are
not limited to, Grignard reactions, Gilman reagents, Aldol reaction, enamine acylation, Wittig
reaction, and Claisen and Dieckmann condensations.52 After careful consideration, the Wittig
reaction was selected as a key step in forming the crucial C4-C5 bond as an olefin, and further
elaboration projected using aminohydroxylation protocols.
2.4 Synthetic Approach Utilizing the Wittig Reaction
The Wittig reaction is perhaps the most commonly used reaction for the construction of
alkenes.53 The Wittig reaction occurs between a carbonyl (usually an aldehyde or ketone) and a
phosphonium ylide 2.27 to yield the desired alkene 2.28 and phosphine oxide 2.29 as a byproduct, see Scheme 9. The configuration of the alkene generated from the Wittig reaction is
highly dependent on the nature of the phosphonium ylide employed. The Z-selective reaction is
favored with unstabilized ylides, while E-selective reactions require stabilized ylides (the
substituents on the carbon are conjugating or anion stabilizing, such as a carbonyl group).
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Scheme 9

Wittig reactions are often implemented because most require mild condition, starting materials
are generally easily obtained, and ylides are usually tolerant to a number of functional groups.53
Therefore, the synthetic protocols envisioned towards the synthesis of ascaulitoxin aglycone
incorporated the Wittig reaction as a key step as shown in the retro-synthesis, Figure 2.4.

Figure 2.4 Retro-synthesis
The retro-synthetic approach invokes the use of key alkene 2.30, obtained from a Wittig reaction
between phosphonium ylide 2.31 and aldehyde 2.3. An aminohydroxylation reaction of 2.30
would generate the requisite aminohydroxy moiety found in ascaulitoxin aglycone. In line with
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previous chemistry, this approach also employed methionine (2.5) as the starting material
2.5 Synthetic Route: Wittig Reaction
One of the advantages to the Wittig approach is the utilization of some of the
intermediates previously obtained from the Henry approach. As shown in Scheme 10 compound
2.16, derived from methionine, was used as a key intermediate. The route was modified to
include initial benzyl protection of the acid yielding 2.32, followed by N-Cbz protection of the
amine to yield protected analog 2.33 in excellent yields. Compound 2.33 is also an important
precursor since alkyl halides are necessary for the generation of the requisite phosphonium ylides
used in the Wittig reaction.
Scheme 10a

Protected bromoalkane 2.33, at first glance, appeared to be a suitable substrate for reaction with
triphenylphosphine, a stable precursor for ylide generation. (Scheme 11).54, 55

37

Scheme 11a

Initial reactions of 2.33 with triphenylphosphine in chloroform at reflux yielded a white
precipitate that did not correspond to phosphonium bromide product 2.34. Filtration of the solid
and subsequent washing with acetone afforded as the major product
benzyltriphenylphosphonium bromide 2.36. (Scheme 12) Although not isolated, mass spectral
evidence revealed the collateral formation of deprotected olefin 2.35.

Scheme 12a

Mechanistically, formation of both of these products is consistent with initial
displacement of the bromide with triphenylphosphine. Elimination of triphenylphosphine
hydrobromide results in a reactive reagent, which further reacts with the benzyl ester resulting in
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the formation of free carboxylic acid and benzyltriphenylphosphoniumbromide. Reactions
conducted at room temperature were sluggish and generated salt 2.34 in 20 % yield after 48
hours. Success was realized when the reaction was conducted at 50 oC, and in this capacity,
product 2.34 was produced in 75% yield, with less than 10% of the side product 2.36. The
product was purified from the side product using silica gel column chromatography, employing a
15% isopropanol/85% chloroform mobile phase. With the phosphonium salt 2.34 in hand, a
revised synthesis for the aldehyde coupling partner was investigated. The protected aldehyde
(compound 2.11) was successfully prepared for use in the Henry reaction protocols, however the
synthesis was sub-optimal and additional reactions were explored. After an extensive survey of
the literature a variation of the Ganem oxidation was selected, which allowed for the use of alkyl
halide 2.33, see Scheme 13.56 The Ganem oxidation employs amine oxides as oxidants, and most
commonly pyridine-N-oxide or trimethylamine N-oxide (TMANO) is used. A number of reaction
conditions were explored, and chloroform was identified as the optimal solvent. Other solvents
commonly used in the Ganem oxidation (dimethyl sulfoxide, dimethylformamide, acetonitrile)
led to undesirable side products and low yields of aldehyde.

Scheme 13a
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Using the Ganem oxidation was a drastic improvement to earlier chemistry used to
produce aldehydes from homoserine precursors. The direct conversion of alkyl bromide 2.33 to
aldehyde 2.11 eliminated lactonization, and it afforded the aldehyde in a single step in modest
yield. Moreover, the common intermediate 2.33 was used to synthesize both Wittig coupling
partners, the phosphonium bromide 2.34 and the aldehyde 2.11.
2.6 Exploring the Wittig Reaction
The Wittig reaction has been used for the past 60 years to construct alkenes derived from
simple building blocks, or complex synthetic molecules.53 Its utility should not go unappreciated
insofar as it has provided chemists with a robust alternative for the synthesis of alkenes. With
both the phosphonium salt and aldehyde available in reasonable quantities, attempts to form
target alkene 2.37 were initiated. In advance of performing the Wittig reaction, the judicious
selection of base was warranted. There are three types of ylides that can be formed in the Wittig
reaction from phosphonium or phosphorane precursors: non-stabilized, semi-stabilized, and
stabilized.53 The reactivity for each of these ylides are slightly different. Non-stabilized ylides
are generally aliphatic ylides, meaning that they are not in conjugation with any other
substituent. Semi-stabilized ylides possess conjugation and usually contain a phenyl or alkenyl
adjacent to the ylide. Stabilized ylides contain a carbonyl, ester, nitrile, or sulfone attached to the
-carbon and are typically stable to hydrolysis in air.53 The reaction of non-stabilized ylides with
aldehydes is scant in the literature, and most reactions reported with amino acid substrates have
been wrought with issues, including racemization, elimination, and lack of reactivity. However,
a recent report documented the use of silver carbonate as a base for the generation of nonstabilized ylides using complex aldehydes and phosphonium salts.57 Reaction of 2.34 with silver
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carbonate in acetonitrile for 1 hour at room temperature, followed by addition of aldehyde 2.11
failed to afford alkene 2.37, even after stirring for 48 hours, see Scheme 14.

Scheme 14a

TLC and LC-MS reaction evaluation over time revealed the formation of benzyl alcohol and
additional intractable material. The formation of benzyl alcohol is consistent with the initial
formation of the ylide, which then may undergo internal cyclization to yield phosphorane 2.38.
Although phosphorane 2.38 was not isolated from the reaction, additional experiments helped to
confirm its formation. Namely, when 2.34 was reacted with silver carbonate in acetonitrile at
room temperature in the absence of aldehyde, TLC and MS monitoring revealed the formation of
benzyl alcohol. The initial ylide formed must experience intramolecular cyclization to
phopshorane 2.38 with the expulsion of benzyl alcohol. In order to trap the ylide to prevent this
intramolecular cyclization, 2.34 and aldehyde 2.11 were premixed in advance of silver carbonate
addition. Unfortunately, under these conditions, the formation of the alkene product was not
observed. Due to the instability of the ylide derived from 2.34, and the lack of reactivity in the
Wittig reaction, this synthetic strategy was abandoned. Insights from both the Henry and Wittig
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approach were used in the construction of a final approach, namely, the use of the Grubbs
metathesis reaction as a key step for forming the C4/C5 bond.
2.7 Grubb’s Approach
In an effort to form the elusive C4-C5 carbon-carbon bond for the synthesis of
ascaulitoxin aglycone, it became obvious that an alkene intermediate would represent the most
direct and viable approach. In this capacity, olefin metastasis reactions were selected to
represent the critical carbon-carbon bond forming step. The downside to this new approach is
that it required deviation from the starting materials and synthetic precursors previous optimized.
2.8 Synthetic Rational for Utilizing Olefin Cross Metathesis
This approach took advantage of olefin cross metastasis reactions, which have
historically provided chemists with a robust method to synthesize highly functionalized alkenes
from less complex precursors.58 There are three basic categories of olefin metastasis: ringopening metathesis polymerization (ROMP), ring-closing metathesis (RCM), and olefin cross
metathesis. Olefin cross metathesis reactions have intrinsic problems that prevent them from
being utilized to the same extent as ROMP or RCM. Factors include, but are not limited to, low
catalytic activity due to the lack of a strong enthalpic driving force, such as release of ring strain
in ROMP, lack of entropic advantages of intramolecular reactions (RCM), and poor product
selectivity (homodimerization).58
Olefin metathesis success largely depends on catalysts selection. Commonly, ruthenium
catalysts are used but there are a growing number of new catalysts employed that contain metals
such as, Mo, W, and Re.59 As this field has expanded, more reactive catalysts have been
synthesized (Figure 2.5) to overcome issues of low reactivity while increasing functional group
tolerance.
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Figure 2.5 Ruthenium Catalysts

Even with advances in developing better catalysts for olefin cross metathesis, a reaction’s
success is highly substrate dependent. An olefin’s ability to cross-couple can be hard to predict
accurately due to the complex interplay of steric and electronic factors.58 Therefore, the
reactivity of alkenes are often categorized based on their ability to homodimerize, see Scheme
15.

Scheme 15

The reactivity if each alkene is not measured in absolute reactively, but rather measured in
relative reactivity compared to the reactivity of other alkenes. These are categorized into four
types based on coupling reaction rates. Type I are categorized as alkenes that undergo rapid
43

homodimerization and the homodimer can continue in cross metathesis reactions. Type II olefins
homodimerize slowly and their homodimer can only continue to undergo cross-coupling
sparingly. Type III cannot undergo homodimerization but can undergo cross metathesis with
type I and type II homodimers. Type IV alkenes do not participate in cross metathesis but they
do inhibit the catalysts from facilitating coupling between the other types, see Figure 2.6.58

Figure 2.6 Olefin Categorization and Rules for Selectivity

In order to utilize the olefin cross metathesis reaction, a retrosynthetic approach requires olefin
4.1, which is categorized as type I. It is important to understand what type of olefin is used, since
it points to the appropriate selection of catalyst, see Scheme 16.
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Scheme 16

Similar to the chemistry protocols outlined in the Wittig approach, alkene 2.30 represented a key
intermediate, derived from alkene 2.39. Alkene 2.39 represents the olefin required (containing
one additional carbon) for the cross metathesis reaction; key olefin 2.30 would serve as a
substrate for an aminohydroxylation reaction generating the C4-C5 amino hydroxyl unit found in
ascaulitoxin aglycone. Intermediate 2.39 can be derived from an indium allylation of substrate
2.40.

2.9 Synthetic Approach Utilizing Olefin Cross Metathesis
In order to take advantage of olefin cross metathesis reactions, the required substrate Dallylglycine was required. D-allylglycine is commercially available, but only through one vendor,
at a cost of $50 per gram. In order to overcome this cost restriction, an asymmetric synthesis of
D-allyglycine was accomplished. The condensation of ethyl glyoxylate 2.41 with the chiral
auxiliary (R)-(+)-tert-butylsulfinamide afforded analog 2.40, see Scheme 17.60
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+Scheme 17a

The success of this reaction was determined by an increase in Rf, mass analysis yielded the
correct m/z 260 (M+Na+MeOH), and diagnostic tert-butyl group 1HNMR resonance at 1.07 ppm.
Compound 2.40 was then subjected to an indium allylation to yield allyl product 2.42 in
respectable yield and high diastereomeric excess (DE). The spectral data and optical rotation
matched the reported compound, and the DE was 96%.61
Reactions that allow for selectivity in the formation new stereogenic centers are a
powerful tool in the synthesis of natural products and potential drug candidates. Metal-mediated
asymmetric allylations of various imines and carbonyls continue to provide effective ways to
produce chiral amines and alcohols. Indium-mediated asymmetric Barbier-type allylation is no
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exception. It is a carbon-carbon bond forming reaction that is similar to the Grignard reaction but
with the advantages of being performed in one-pot using milder experimental conditions.62
Protected allylglycine 2.42 was subjected directly to the olefin cross metathesis reaction
to afford alkene 2.43.63 Repeated reactions of 2.42 using standard olefin metathesis protocols
were moderately successful at best, as measured by product yield, reaction time, and starting
material remaining. Literature precedent revealed that homodimerization of protected
allylglycine derivatives is difficult and requires subsequent scaffolding with catechol to convert
olefin cross metathesis reaction to ring closing metathesis using a Grubbs 1st generation
catalyst.64 For our synthetic purposes, attempts were focused on avoiding the RCM pathway if at
all possible. Another report demonstrated that suitably protected allylglycine substrates
experienced olefin cross metathesis reactions using Grubbs 2nd generation catalysts with modest
success.63 Therefore, the allylglycine cross metathesis reaction was optimized with respect to
solvent, temperature, catalyst, and catalyst loading, see Figure 2.7.
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Figure 2.7

After a number of unsuccessful reactions, optimal conditions were achieved with the use of
dichloromethane as a solvent and sequential degassing of the solvent prior to the addition of the
Grubbs catalyst. Yields were maintained and reaction times decreased to 24 hours with the use
of catalytic CuI in the olefin metathesis reaction. The exact mechanism by which CuI increases
the catalytic activity is unknown.65 It was hypothesized that iodide helps to stabilize the Ru
complex however, further experimentation with NaI proved otherwise.65 The success of the
Grubbs olefin metathesis reaction generated suitable quantities of material to investigate the next
sequence, namely, the Sharpless asymmetric aminohydroxylation reaction of alkene 2.43.
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2.10 Sharpless Asymmetric Aminohydroxylation
The Sharpless asymmetric aminohydroxylation was first reported in 1996 and allows for
catalytic syn-addition of aminoalcohols in a single step, see Figure 2.8.66 The significant of this
reaction immediately apparent to many researchers as it was straightforward route to a variety of
biologically important aminoalcohols and natural products. It also contributed to the body of
work that Sharpless pioneered and was later awarded the Noble Prize in Chemistry in 2001.67
Sharpless asymmetric aminohydroxylation is a metal catalyzed reaction that employs Osmium
(IV) species that adds syn-specifically to an alkene - probably via a (3+2) cycloaddition however,
another possible mechanism includes a (2+2) cycloaddition followed by a ring-expanding
migration, see Figure 2.8.

Figure 2.867
Although some theoretical calculations suggest that (3+2) mechanism is the most plausible, the
bond-forming step needs further investigation.68 One drawback to the aminohydroxylation
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reactions is the suitable control of regiochemistry if R1 ≠ R2 however; in our case R1 = R2 so it
eliminates the possibility of additional undesired diastereomers, see Figure 2.9.67

Figure 2.9

When performing an aminohydroxylation reaction it is important to select the appropriate amine
source. Chloramine-T [TsN(Na)Cl] and chloramines-M [MsN(Na)Cl] are commonly used amine
salts that usually afford crystalline products.67 The major issue encountered using these amine
sources is that sulfonamide protecting groups usually require harsh condition to produce the free
amine.67 To avoid these harsh conditions we choose a carbamate amine source that can be easily
deprotected under mild reaction conditions, see Scheme 18.69
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Scheme 18a

Another benefit to this reaction is the production of only two possible diastereomers, 2.44 and
2.45. When the Sharpless aminohydroxylation reaction was conducted under standard conditions
(osmium tetroxide potassium, TsONCOOBn, acetonitrile/water) with olefin 2.43, diastereomers
2.44 and 2.45 were produced in a 60-40 ratio respectively. Mass spectral data supported the
correct molecular mass of the product, and 1H-NMR confirmed the presence of two
diastereomers. In an attempt to explore deprotection strategies, the diastereomers were subjected
to treatment with aqueous HCl (6 N). Monitoring the reaction using mass analysis, reaction at 40
o

C generated N-sulfonylimine deprotection; increasing the temperature to 90 oC target

temperature resulted in the deprotection of the N-CBz group, followed by sequential deprotection
of the ester groups. Mass analysis revealed that our final product was present but as a mixture;
the acid had also catalyzed lactone formation. We also attempted other deprotection strategies
that would allow us to avoid the use of acid at high temperatures. We used HCl (1 N) to first
deprotect N-sulfonylimine at RT successfully; followed by treatment with hydroxide base to
cleave the ethyl esters however, these attempts failed. Although diastereomers 2.44 and 2.45
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were inseparable by conventional chromatographic methods, the mixture was reacted with 4bromobenzoic acid under standard DCC coupling conditions. (Scheme 19)

Scheme 19a

Once protected, the two diastereomers were separated using semi-preparative normal phase
HPLC. The only drawback to this approach is that the deprotection strategy required harsh
acidic conditions; side reactions including lactonization was evident by LCMS and 1H-NMR
evaluation.
A new protection and deprotection strategy was devised that incorporated the use of
benzyl protection on both the carboxylic acids and N-Cbz protections on the amine groups. This
approach would result in generating the final deprotected molecule in a single step using mild
catalytic hydrogenation conditions, see Scheme 20.
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Scheme 20a

Starting from commercially available D-allylglycine allowed us to immediately protect the
carboxylic acid group through acid catalyzed esterification with benzyl alcohol to afford
intermediate 2.49 as white solid, confirmed by MS and 1HNMR spectral data. N-Cbz protection
of the amine 2.50 was accomplished as before using benzyl chloroformate. Protected alkene 2.50
was subject to cross metathesis using Grubbs II generation catalyst as previously described
yielding intermediate 2.51. The Grubbs cross metathesis reaction success is highly functional
group dependent and to our benefit the benzyl and N-Cbz protecting groups were well tolerated
leading to higher yields. The aminohydroxylation reaction was performed as previously
described to yield two diastereomers 2.52 and 2.53. The presents of diastereomers were evident
by examination of the 1H-NMR.
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2.11 Benzyl and N-Cbz Deprotection
The next step in our synthetic pathway is to optimize our deprotection strategy. The
deprotection of benzyl and N-Cbz protecting groups have been performed in one-pot using
catalytic hydrogenation or catalytic transfer hydrogenation.70-72 We attempted to use both of
these techniques on a diastereomeric mixture of compounds 2.52 and 2.53 varying catalyst,
hydrogen source, solvent and temperature, these conditions are summarized in Table 2.1. We
monitored each of these reactions using LC-MC but failed to detect our desired product 2.55.

Table 2.1
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Our LC-MS analysis did however suggest that various N-Cbz groups and benzyls protecting
groups were being removed but the reaction would not progress to completion. It is known that
once amines are deprotected that they can poison palladium catalyst due to their basic nature.73
We tried to overcome this problem by adding acetic acid to protonate the amine once it formed.
This method also proved unsuccessful for us. It is possible that with the number of amines
present in our compounds that once the amines are deprotected and protonated by the acid that
solubility then becomes an issue.
2.12 Conclusion
Herbicides are the most utilized weed management tool by farmers globally. Resistance
issues have cost farmers both by reducing herbicides effectiveness and lower crop yields. It is
clear that new herbicides with unique molecular targets are needed. Natural products provide
access to both chemically diverse scaffolds and novel mechanisms of action. One such natural
product that meets this criterion is ascaulitoxin aglycone.
In our efforts to synthesize the natural product herbicide (2R,4S,5S,7R)-2,4,7-triamino-5hydroxyoctanedioic acid, ascaulitoxin aglycone, we explored three synthetic routes. The first
approach we employed took advantage of using the cheap available amino acid methionine. We
first attempted to employ homoserine as a key intermediate. However; continuous problems
with lactonization led us to seek an alternative pathway. We avoided homoserine as an
intermediate by ring-opening the lactone with HBr in acetic acid or dimethylhydroxylamine
affording the alkyl halide, 2-amino-4-bromobutanoic acid or 2-amino-4-hydroxy-N-methoxy-Nmethylbutanamide. These intermediates were used to generate both the nitroalkane and aldehyde
used in critical carbon-carbon bond forming step, the Henry reaction. We were unsuccessful in
our efforts to make the desired nitroalcohol product in appropriate yields. This may be due to a
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number of factors such as steric or electronic effects based on the complexity of our coupling
partners.
The next route we explored utilized the Wittig reaction to establish our eight carbon
framework. Again we started with the amino acid methionine and took advantage of earlier
chemistry to synthesize the alkyl halide intermediate from which the ylide and aldehyde are
derived. The Wittig approach was unsuccessful due to ylide instability. After the addition of base
we observed ylide degradation and the production of benzyl alcohol, with or without aldehyde
present. Although both the Henry and Wittig approaches seemed like reasonable strategies,
inherent reactivity issues led us to pursue the Grubbs cross metathesis reaction as an alternate
approach.
Grubbs cross metathesis had been previously implemented in the terminal olefin coupling
of allylglycine. Therefore our strategy employed the use of protected allylglycines as substrates
to the Grubbs metathesis. We were able synthesize D-allylglycine through an indium-mediated
asymmetric allylation. Obtaining D-allylglycine allowed us to execute a Grubbs cross metathesis
reaction to yield an allylglycine homodimer, our critical alkene intermediate. The alkene was
then subjected to aminohydroxylation to afford the desired aminoalcohol intermediate. We
implemented two different deprotection strategies. Our first deprotection strategy proved to be
too harsh and the acidic condition caused lactonization. Our second strategy allowed for a onepot deprotection under milder condition.
Our efforts to synthesize the natural product herbicide ascaulitoxin aglycone have
yet to be realized; however we have made significant progress toward this goal. The information
gained from the Henry and Wittig pathway helped tremendously in selecting our final approach.
The Grubbs cross metathesis is a promising pathway that has overcome our pervious synthetic
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issue of forming the critical bond between C-4 and C-5.
2.13 Future Work
As this research continues the next reaction that demands additional attention is the
deprotection of the COOBn and N-Cbz protected aminoalcohol intermediate. Under standard
conditions, catalytic hydrogenation is usually the most direct approach for the deprotection of
both benzyl and carbamate functional groups. However, the judicious choice of catalyst may be
important to achieve successful deprotection. Once a deprotection strategy has been successfully
optimized the mixture of diastereomeric products should be tested for herbicidal activity. This
will confirm if the molecular target site can accommodate both diastereomers.
To complete the total synthesis of ascaulitoxin aglycone the newly synthesized
diastereomers need to be separated. A similar strategy can be implemented by protecting the
secondary alcohol with an appropriate protecting group; capping the secondary should allow for
the separation of each diastereomer by silica gel flash chromatography or normal phase HPLC.
Once pure diastereomers are obtained attempts should be made to grow crystals for X-ray
crystallography. X-ray crystallography would allow for the assignment of the absolute
configuration. This is the only way to determine the absolute configuration of these molecules. Jbased analysis approaches cannot be used since there is a lack of empirical data for aminoalcohol
systems, unlike diols that have been study extensively. Once separated, the diastereomers should
be deprotected; NMR data can be compared with the natural product to determine which
diastereomer matches the reported literature. Finally the diastereomers should be tested
separately for herfbicidal activity.
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EXPERIMENTAL

General
All amino acid starting materials were purchased from Acros Organics, Inc. Chromatography
solvents were purchased as certified A.C.S. grade from Fisher Scientific. All reagents were
purchased from Sigma-Aldrich or Acros Organics, Inc. Thin layer chromatography (TLCs) was
ran on Merck silica gel 60 F254 aluminum sheets. To visualize TLCs both UV light and staining
reagents such as phosphomolybdic acid and potassium permanganate solutions were used. Flash
Chromatography was performed using standard grade silica gel particle size of 32-62 m from
Sorbent Technologies. 1H NMR and 13C NMR spectrums were recorded using Bruker 400 or
500 MHz instruments. Low resolution mass spectral data was acquired using Waters ZQ
platform, using either ESI+ or ESI- electrospray ionization. Elemental Analysis was performed
on a Perkin Elmer Series II 2400 CHNS/O elemental analyzer. Optical and specific rotations
were measured using a Rudolph Autopol IV polarimeter at 25o C. Compound purity was
determined using a LC-MS Waters Micromass ZQ/ Water Alliance separation module.
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(S)-(3-amino-3-carboxypropyl)dimethylsulfonium iodide (2.5):
1.00 g (0.0067 mol) of L-methionine was dissolved in 15 mL of H2O and added to a roundbottomed flask equipped with a magnetic stir bar. Then, 1.04 mL (0.0167 mol) of methyl iodide
was added to the solution and the mixture was heated to 40o C. The reaction was allowed to stir
for 20 h. Water was then removed by vacuum distillation until only approximately 10 mL of
water was left in the flask. Ethanol was then added (70 mL) to the solution and a precipitate
began to form. The flask was placed at 4o C overnight to allow precipitate to accumulate at the
bottom of the flask. Precipitate was then filtered off under vacuum and washed with EtOH/H2O
(7:1) mixture and then dried to obtain a white solid, 2.75 g of product in 71 % yield. All data
obtained matched previously reported data.74
mp: 163-168 oC (Lit.74 mp: 163-165 oC); 1H NMR (400 MHz, deuterium oxide) δ 3.85 (td, J =
6.5, 2.5 Hz, 1H), 3.57 – 3.34 (m, 2H), 2.93 (s, 6H), 2.34 (q, J = 7.0 Hz, 2H); m/z (ESI) 164 (M+ I-)
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L-Homoserine

(2.4):

(S)-(3-amino-3-carboxypropyl)dimethylsulfonium iodide 1.00 g (0.00343 mol) was added to 3.2
mL of H2O in a two neck round bottom flask equipped with a magnetic stir bar and a reflux
condenser. Sodium bicarbonate 0.288 g (0.00343 mol) was dissolved in 4.26 mL of H2O and
drawn up into a 6 mL syringe. The reaction was allowed to reach reflux then sodium bicarbonate
was added dropwise via syringe pump over a 4 hour period. The reaction was allowed to run for
24 h. The H2O was then removed by vacuum distillation until colorless oil remained. The oil was
reconstituted in minimal H2O and 3 mL EtOH was an added followed by acetone. Acetone was
added until product precipitated. The product was obtained as a white solid, collected from
vacuum filtration and then dried to give 0.197 g in a 48 % yield. The data that was obtained
agreed with the previous report.74
1

H NMR (400 MHz, deuterium oxide) δ 3.74 (dd, J = 7.3, 5.0 Hz, 1H), 3.67 (td, J = 7.1, 6.5, 2.6

Hz, 2H), 2.11 – 1.98 (m, 1H), 1.97 – 1.86 (m, 1H); DEPT 135 NMR (400 MHz, D2O) δ 58.65,
53.39, 32.14; m/z ESI 120 (MH+)
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((Benzyloxy)carbonyl)-L-homoserine (2.8):
L-homoserine

0.300 g (0.00252 mol) was added to a round bottom flask containing 10.3 mL of 1

N NaHCO3. The reaction was then cooled to 5o C and benzyl chloroformate 0.54 mL (0.00378
mol) was added dropwise over 1 h. The reaction was then allowed to stir overnight. The reaction
was then extracted with ether (2 x 15 mL). The aqueous layer was then placed on an ice bath and
acidified carefully to pH 2 – 3 with 1 N HCl. Then the aqueous layer was extracted with EtOAc
(3 x 20 mL). The organic layer was then dried with Na2SO4, filtered, and the solvent was
removed under reduced pressure. The resulting oil (0.478 g; 76 % yield) was directly used in
next step. Data matched previously reported literature.75
1

H NMR (400 MHz, methanol-d4) δ 7.34 (dt, J = 21.3, 7.3 Hz, 5H), 5.10 (s, 2H), 4.23 (dd, J =

8.7, 4.7 Hz, 1H), 3.65 (dd, J = 9.5, 4.0 Hz, 2H), 3.34 – 3.31 (m, 2H), 2.15 – 2.01 (m, 1H), 1.91 –
1.80 (m, 1H); m/z ESI 254 (MH+)

Benzyl ((benzyloxy)carbonyl)-L-homoserinate (2.9):
((Benzyloxy)carbonyl)-L-homoserine 0.25 g (0.00073 mol) was dissolved in EtOH (5 mL) and
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added to a round bottom flask equipped with a magnetic stir bar. NaOH 0.029 g was dissolved in
1 mL of H2O and was subsequently added to the reaction. The reaction was allowed to stir for 4
h, and the solvent was removed under reduced pressure and reconstituted in DMF (5 mL).
Benzyl bromide 0.17 mL (0.00146 mol) was then added dropwise and the reaction was allowed
to stir overnight. The reaction was then quenched with H2O and extracted with EtOAc (3 x 15
mL). The organic layer was dried with Na2SO4, filtered, and solvent was removed under reduced
pressure. The crude product obtained as a white solid (0.088 g) was purified using normal phase
Si gel flash chromatography (EtOAc: hexanes, 4:6) affording a 35 % yield. Data matched
previously reported literature.75
Rf = 0.35 (EtOAc: Hex; 6: 4); []D = -29.1o (c = 0.1, MeOH); 1H NMR (400 MHz, chloroformd) δ 7.37 (s, 10H), 5.72 (s, 1H), 5.20 (s, 2H), 5.13 (d, J = 2.2 Hz, 2H), 4.65 – 4.57 (m, 1H), 3.80
– 3.60 (m, 2H), 2.88 (bs, 1H), 1.82 – 1.66 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 172.38,
156.79, 136.05, 135.16, 128.65, 128.57, 128.54, 128.29, 128.15, 67.39, 67.29, 58.36, 51.40,
35.54; m/z ESI 344 (MH+)

Benzyl (S)-2-(((benzyloxy)carbonyl)amino)-4-oxobutanoate (2.11):
Benzyl ((benzyloxy)carbonyl)-L-homoserinate 0.14 g (0.00041 mol) in anhydrous CH2Cl2 was
added Dess-Martin periodinane 0.191 g (0.00045 mol). The reaction was stirred for 2 h at room
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temperature. The solvent was removed and suspended in aqueous NaHCO3/Na2S2O3 solution
(100 mL NaHCO3 containing 25 g of Na2S2O3) and extracted with Et2O (3 x 20 mL). The
organic layer was then washed with brine and dried over Na2SO4. The organic layer was filtered
and solvent was removed under reduced pressure. The crude product (white amorphous solid;
0.116 g) was purified using normal phase flash chromatography affording an 83 % yield. All
data obtained matched that of the previously reported product.75
1

H NMR (400 MHz, chloroform-d) δ 9.71 (s, 1H), 7.54 – 7.16 (m, 10H), 5.75 (d, J = 8.4 Hz,

1H), 5.19 (d, J = 2.4 Hz, 2H), 5.13 (s, 2H), 4.71 (dt, J = 9.0, 4.8 Hz, 1H), 3.11 (qd, J = 18.5, 4.9
Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 199.20, 170.56, 155.96, 136.04, 135.03, 128.66, 128.57,
128.31, 128.22, 128.12, 67.70, 67.18, 49.15, 45.78; m/z ESI 396 (M+MeOH+Na+)

Benzyl (S)-2-(((benzyloxy)carbonyl)amino)-4-iodobutanoate (2.12):
((Benzyloxy)carbonyl)-L-homoserine 0.2 g (0.00058 mol) was added to a round bottom flask
containing MeCN/Et2O (1:4) and the solution was cooled to 0o C. Subsequently,
triphenylphosphine 0.167 g (0.000638 mol) and imidazole 0.043 g (0.000638 mol) were added,
followed by the addition of iodine until a brown color persists. After stirring for 1 h at 0o C the
reaction was allowed to warm to room temperature over 2 h. Upon reaction completion the
reaction was diluted with Et2O (20 mL) and H2O (10 mL). The organic layer was collected and
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washed with aqueous sodium bisulfate and brine. The organic layers were then dried with
sodium sulfate, filtered, and solvent was removed under reduced pressure. The crude product
0.168 g was purified using normal phase flash chromatography EtOAc: Hexanes (3:7) to obtain
64 % yield. Data matched previously reported literature.76
1

H NMR (400 MHz, chloroform-d) δ 7.38 (s, 10H), 5.45 – 5.38 (m, 1H), 5.20 (s, 2H), 5.13 (s,

2H), 4.52 – 4.43 (m, 1H), 3.19 – 3.07 (m, 2H), 2.50 – 2.39 (m, 1H), 2.23 (dq, J = 13.8, 7.4 Hz,
1H); 13C NMR (101 MHz, CDCl3) δ 171.07, 155.89, 136.02, 134.98, 128.72, 128.65, 128.59,
128.35, 128.30, 128.17, 67.58, 67.25, 54.81, 36.82; m/z ESI 454 (MH+)

(R)-2-oxotetrahydrofuran-3-aminium bromide (2.15):
D-methionine

10 g (0.067 mol) was added to a 250 mL round-bottomed flask containing 40 mL

H2O, 40 mL isopropanol, and 16 mL AcOH equipped with a magnetic stir bar and reflux
condenser. Bromoacetic acid 10.8 g (0.078 mol) was then added to the mixture and the reaction
was then heated to 50o C until reaction was homogeneous. Once the reaction was homogeneous
the reaction was heated to reflux for 2.5 h. The reaction was allowed to cool to room
temperature. The solvent was then removed under reduced pressure. To remove the H2O from
the reaction, a mixture of toluene: isopropanol (1:1) was used as an azeotrope. After the solvent
was removed a thick oil remained. The oil was dissolved in 60 mL of 4 N HCl in dioxane. Upon
stirring the product a pink solid precipitated. The product 9.02 g was collected by filtration and
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washed with isopropanol and cooled to -78o C to give 74 % yield of product. All data obtained
matched the reported literature.77
mp: 238-240 oC (Lit.78 mp: 236-238 oC); []D = 22.0 (c = 0.1, MeOH); 1H NMR (400 MHz,
deuterium oxide) δ 4.57 (t, J = 9.2 Hz, 1H), 4.42 (q, J = 11.5 Hz, 2H), 2.92 – 2.71 (m, 1H), 2.41
(p, J = 11.3 Hz, 1H); 13C NMR (101 MHz, D2O) δ 174.51, 67.40, 48.57, 26.77; m/z ESI 103
(MH+ -Br)

(R)-3-Bromo-1-carboxypropan-1-aminium bromide (2.16):
(R)-2-Oxotetrahydrofuran-3-aminium bromide 1.00 g (0.0055 mol) was added to a sealed tube
equipped with a magnetic stir bar. Then 10 mL of HBr in glacial AcOH 33 % (w/w) was added
to the tube. The tube was sealed and reaction was allowed to stir for 5.5 h at 100o C. The reaction
was then removed from the oil bath and allowed to cool to RT. The cooled tube was opened with
extreme caution (HBr gas!!) and diluted with Et2O. The white solid was then vacuum filtered and
washed with Et2O to give 1.17 g of product (81 % yield). All data obtained matched the reported
literature reference.79, 80
[]D = 8.00 (c = 0.1, H2O); 1H NMR (400 MHz, deuterium oxide) δ 4.17 (t, J = 6.7 Hz, 1H), 3.57
(ddt, J = 17.5, 10.8, 5.4 Hz, 2H), 2.51 (dq, J = 13.2, 6.5 Hz, 1H), 2.35 (dd, J = 15.1, 6.8 Hz, 1H);
13

C NMR (101 MHz, D2O) δ 67.33, 51.52, 48.51, 32.76, 27.97, 26.73; m/z ESI 183 (MH+) 185

(MH+, Br)
65

(S)-4-Bromo-1-methoxy-1-oxobutan-2-aminium chloride (2.17):
(S)-3-Bromo-1-carboxypropan-1-aminium bromide 6.4 g (0.0243 mol) was added to a roundbottomed flask charged with 50 mL anhydrous MeOH and a magnetic stir bar. The reaction was
then cooled to 0o C and then SOCl2 was added dropwise. The reaction was stirred for 10 min. and
the ice bath was removed and reaction was allowed to warm to RT and stirred overnight. Solvent
was then removed under reduced pressure to yield yellowish/orange oil. Et2O was then added
and the reaction was stirred vigorously until a precipitate was formed. The solid was collected
using vacuum filtration and washed with EtOAc to afford 6.15 g of product (white solid) in a
91.4 % yield. All data obtained matched the reported literature reference 80
1

H NMR (400 MHz, deuterium oxide) δ 4.31 (q, J = 6.6, 6.1 Hz, 1H), 3.81 (d, J = 1.2 Hz, 3H),

3.77 – 3.51 (m, 2H), 2.81 – 2.68 (m, 1H), 2.53 (dt, J = 13.4, 6.7 Hz, 1H), 2.47 – 2.24 (m, 2H).

Methyl (S)-2-(((benzyloxy)carbonyl)amino)-4-bromobutanoate (2.18):
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(S)-4-Bromo-1-methoxy-1-oxobutan-2-aminium chloride 6.00 g (0.0217 mol) was added to a
stirring solution of KHCO3 10.86 g (0.1085 mol) in 40 mL of H2O. The reaction was then cooled
to 0o C and benzyl chloroformate 3.41 mL (0.0239) was added dropwise over 1 h. The reaction
was then allowed to warm to RT and stir for 18 hours. The reaction was worked up with H2O/
Et2O, and the organic phase was washed with brine and dried with MgSO4. The organic layer
was filtered and solvent was removed under reduced pressure. The crude product 5.67 g was an
oil that solidified after placing under high vacuum affording product in a 79 % yield. All data
obtained matched the reported literature reference.81
1

H NMR (500 MHz, chloroform-d) δ 7.38 (s, 5H), 5.49 – 5.36 (m, 1H), 5.15 (s, 2H), 4.59 – 4.47

(m, 1H), 3.79 (s, 3H), 3.45 (t, J = 6.9 Hz, 2H), 2.52 – 2.42 (m, 1H), 2.27 (dd, J = 13.6, 6.7 Hz,
1H). m/z ESI 332(MH+) 334(MH+, Br)

Benzyl (S)-2-(((benzyloxy)carbonyl)amino)-4-iodobutanoate (2.19):
Benzyl (S)-2-(((benzyloxy)carbonyl)amino)-4-bromobutanoate 1.00 g (0.003 mol) was added to
a round-bottomed flask equipped with a magnetic stir bar and charged with 22 mL acetone.
Sodium iodine 0.918 g (0.006 mol) was then added and the reaction was heated to 60o C. The
reaction was allowed to stir for 2 h and was subsequently cooled to RT. The reaction was
quenched with H2O/Et2O and the organic layers were collected, combined, and dried with
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sodium sulfate. The reaction was then filtered and solvent was removed under reduced pressure
yielding the product as a yellow oil (1.1 g). This product was taken to the next step without
further purification.82
1

H NMR (400 MHz, Chloroform-d) δ 7.38 (s, 9H), 5.45 – 5.38 (m, 1H), 5.20 (s, 2H), 5.13 (s,

2H), 4.52 – 4.43 (m, 1H), 3.20 – 3.07 (m, 2H), 2.53 – 2.39 (m, 1H), 2.23 (dq, J = 13.8, 7.4 Hz,
1H); 13C NMR (101 MHz, CDCl3) δ 171.07, 155.89, 136.02, 134.98, 128.72, 128.65, 128.59,
128.35, 128.30, 128.17, 67.58, 67.25, 54.81, 36.82, -0.99.

Methyl (S)-2-(((benzyloxy)carbonyl)amino)-4-nitrobutanoate (2.20):
Methyl (S)-2-(((benzyloxy)carbonyl)amino)-4-iodobutanoate 1.1 g (0.003 mol) was added to a
round-bottomed flask equipped with a magnetic stir bar and 10 mL DMF. Sodium nitrite 0.403 g
(0.006 mol) was added and the reaction was allowed to stir at RT for 2 h. The reaction was
quenched with 20 % NaCl and extracted with EtOAc. Organic layers were combined and dried
with sodium sulfate, filtered, and solvent was removed. Product was purified using HPLC C18
reverse phase column using 40 % acetonitrile/H2O as the mobile phase. The wavelengths of 215
and 210 were monitored, with the product retention time of 3.0 min. The HPLC fractions were
evaporated under reduced pressure to yield 0.263 g, 30 % of product. All data obtained matched
the reported literature reference.83
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1

H NMR (400 MHz, chloroform-d) δ 7.37 (s, 5H), 5.48 – 5.32 (m, 1H), 5.13 (s, 2H), 4.53 (q, J =

7.3 Hz, 1H), 3.78 (s, 3H), 3.43 (t, J = 6.9 Hz, 2H), 2.47 (dt, J = 13.0, 6.2 Hz, 1H), 2.25 (dq, J =
13.7, 6.2 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 171.88, 155.86, 136.01, 128.56, 128.28,
128.15, 77.34, 77.22, 77.02, 76.70, 67.24, 63.58, 52.83, 52.72, 35.67, 28.02; m/s ESI 297 (MH+)
319 (MNa+)

Benzyl (R)-(2-oxotetrahydrofuran-3-yl)carbamate (2.21):
(R)-2-Oxotetrahydrofuran-3-aminium bromide 4.0 g (0.02198 mol) was added to a roundbottomed flask containing 40 mL H2O, 40 mL Et2O and a magnetic stir bar. Sodium bicarbonate
3.69 g (0.0439 mol) was then added at RT. The reaction was then cooled to 5o C and benzyl
chloroformate 3.45 mL (0.02417 mol) was added drop wise over the next 1 h. The reaction was
then allowed to stir overnight. The reaction was then diluted with dichloromethane, and water
was added. The organic layers were combined and dried with Na2SO4. The reaction was then
filtered and the solvent was removed under reduced pressure. The product was purified by
precipitation from a DCM/pentane solvent mixture to afford 3.5 g of product (67 % yield). A All
data obtained matched the reported literature reference.84
mp: 118-120 oC (Lit.83 mp: 121 oC); []D = 4.00 (c = 0.1, CHCl3); 1H NMR (400 MHz,
chloroform-d) δ 7.37 (s, 3H), 5.39 (s, 1H), 5.15 (s, 2H), 4.44 (q, J = 15.9, 12.3 Hz, 4H), 4.26 (dq,
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J = 9.7, 6.0 Hz, 2H), 2.79 (t, J = 12.2 Hz, 2H), 2.30 – 2.15 (m, 1H).

Benzyl (S)-(4-hydroxy-1-(methoxy(methyl)amino)-1-oxobutan-2-yl)carbamate (2.22):
Aluminum chloride 2.13 g (0.0159 mol) was added to a round bottom flask equipped with a
magnetic stir bar. Next, 100 mL of anhydrous DCM was added and the solution was cooled to 4o
C. Triethylamine 4.44 mL (0.0318 mol) was then added dropwise to the stirring solution over
the next 10 minutes. The reaction was then allowed to warm to RT and after approximately 15
min. the solution became homogeneous. Benzyl (S)-(2-oxotetrahydrofuran-3-yl)carbamate 2.5 g
(0.0106 mol) and N,O-dimethyl hydroxylamine hydrochloride 1.137 g (0.0166 mol) were added
to the reaction and stirred for an additional 5 h. The reaction was cooled to 4o C and water was
added dropwise to quench the reaction. The reaction was then filtered and extracted with DCM.
The organic layer was then dried with Na2SO4 filtered and the solvent was removed under
reduced pressure. The crude product was purified using flash chromatography EtoAc:hex (6:4).
The product (0.553 g) was isolated along with 0.978 g of starting material to give an overall 30
% yield based on unrecovered starting material. All data obtained matched literature reference.85
1

H NMR (400 MHz, chloroform-d) δ 7.35 (s, 5H), 5.88 (d, J = 7.6 Hz, 1H), 5.09 (d, J = 12.3 Hz,

2H), 4.87 (s, 1H), 3.78 (s, 3H), 3.69 (s, 2H), 3.22 (s, 3H), 1.99 (m, J = 39.4 Hz, 2H).
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Benzyl (S)-(1-(methoxy(methyl)amino)-1,4-dioxobutan-2-yl)carbamate (2.23):
Benzyl (S)-(4-hydroxy-1-(methoxy(methyl)amino)-1-oxobutan-2-yl)carbamate 0.70 g (0.00236
mol) was added to a round-bottomed flask equipped with a magnetic stir bar and 30 mL of
anhydrous DCM was added. Dess-Martin periodinane 2.0 g (0.00472 mol) was added to the
reaction and it was allowed to stir for 2 h. The reaction was monitored by TLC (EtOAc:hexanes;
4:6). Upon reaction completion, a 1:1 solution of saturated. NaHCO3 and saturated NaS2O4 were
added successively. The product was extracted with DCM dried with Na2SO4, filtered and the
solvent removed under reduced pressure. The product was purified using flash chromatography.
The product was obtained as an oil that solidified upon refrigeration. Reaction afforded 0.365 g
in a 52 % yield.
1

H NMR (400 MHz, chloroform-d) δ 9.77 (s, 1H), 7.36 (s, 5H), 5.73 (s, 1H), 5.21 – 5.14 (m,

1H), 5.12 (s, 2H), 3.80 (s, 3H), 3.24 (s, 3H), 2.88 (dd, J = 16.7, 4.9 Hz, 1H), 2.72 (ddd, J = 16.8,
7.3, 2.2 Hz, 1H).
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(R)-1-(Benzyloxy)-4-bromo-1-oxobutan-2-aminium (2.32):
D-Allylglycine 6.5 g (0.0247 mol) in 150 mL benzene was treated with p-TsOH 7.05 g (0.0371
mol) and benzyl alcohol 25.58 mL (0.247 mol), connected to a Dean-Stark trap and a condenser,
and heated to 100 oC for 12 h. The reaction was then cooled to RT and concentrated under
reduced pressure. It was then cooled to 0 oC and Et2O was added slowly until a white precipitate
formed. The white solid (product) was collected by filtration and washed with Et2O. 13.1 g of
product was isolated (yield =81 %).
mp: 148-150 oC (Lit.86 mp: 147-148 oC); []D = 22.0 (c = 0.1, MeOH); 1H NMR (400 MHz,
DMSO-d6) δ 7.63 – 7.31 (m, 8H), 7.12 (d, J = 7.8 Hz, 2H), 5.26 (s, 2H), 4.20 (s, 1H), 3.64 (td, J
= 10.4, 5.2 Hz, 2H), 2.37 (dt, J = 15.8, 8.0 Hz, 2H), 2.29 (s, 3H)

Benzyl (R)-2-(((benzyloxy)carbonyl)amino)-4-bromobutanoate (2.33):
(R)-1-(Benzyloxy)-4-bromo-1-oxobutan-2-aminium 5.0 g (0.01125 mol) was added to a roundbottomed flask containing 40 mL H2O and 40 mL of Et2O. Sodium bicarbonate1.89 g (0.0225
mol) was then added at RT. The reaction was then cooled to 5o C and benzyl chloroformate 1.77
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mL (0.0124 mol) was added dropwise over the next 1 h. The reaction was then allowed to stir for
18 hours. The reaction was then diluted with dichloromethane and H2O, and the organic layers
were combined and dried over Na2SO4. Then reaction was then filtered and the solvent was
removed under reduced pressure. The product was precipitated using DCM/pentane to afford 4.4
g of product in 88 % yield.
mp: 60-62 oC (Lit.87 mp: 64 oC) []D = 34.00 (c = 0.1, MeOH); 1H NMR (400 MHz, chloroformd) δ 7.37 (s, 11H), 5.56 (d, J = 7.3 Hz, 1H), 5.20 (s, 2H), 5.14 (s, 2H), 4.63 – 4.53 (m, 1H), 3.40
(t, J = 6.9 Hz, 2H), 2.46 (dd, J = 13.1, 6.0 Hz, 1H), 2.26 (dq, J = 13.7, 6.6 Hz, 1H). 13C NMR
(101 MHz, CDCl3) δ 171.35, 155.94, 136.06, 135.04, 128.70, 128.16, 67.57, 67.23, 53.00, 35.52,
28.10.

(R)-(4-(Benzyloxy)-3-(((benzyloxy)carbonyl)amino)-4-oxobutyl)triphenylphosphonium
bromide (2.34):
Benzyl (R)-2-(((benzyloxy)carbonyl)amino)-4-bromobutanoate and triphenylphosphine was
dissolved in chloroform and heated to 50 oC and continued to stir for 24 h. The product was
purified using silica gel flash chromatography (isopropanol:chloroform;15:85) affording product
in 75 % yield.
1

H NMR (400 MHz, chloroform-d) δ 7.92 – 7.54 (m, 12H), 7.44 – 7.15 (m, 12H), 5.25 – 5.01

(m, 4H), 4.68 (d, J = 6.7 Hz, 1H), 4.19 (d, J = 15.6 Hz, 1H), 3.76 – 3.54 (m, 1H), 2.38 (s, 1H),
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2.21 (s, 1H).

Benzyl (R)-2-aminopent-4-enoate (2.49):
D-allylglycine 2.0 g (0.0132 mol) in 120 mL benzene was treated successively with p-TsOH
3.40 g (0.0198 mol) and benzyl alcohol 13.68 mL (0.132 mol), connected to a Dean-Stark trap
and a condenser and heated to 100 oC for 12 h. The reaction was then cooled to RT and
concentrated under reduced pressure. It was then cooled to 0 oC and Et2O was added slowly until
a white precipitate formed. The white solid (product) was collected by filtration and washed with
Et2O. The product was isolated (4.8 g, yield =95 %). All data obtained matched the reported
literature reference.63
mp: 78-84 oC (Lit.63 mp: 128-129 oC); 1H NMR (400 MHz, Chloroform-d) δ 8.26 (s, 3H), 7.77
(d, J = 8.1 Hz, 2H), 7.42 – 7.20 (m, 6H), 7.09 (d, J = 8.0 Hz, 2H), 5.66 – 5.51 (m, 1H), 5.22 –
4.90 (m, 4H), 4.13 (d, J = 5.5 Hz, 1H), 2.59 (t, J = 6.5 Hz, 2H), 2.33 (s, 3H).

Benzyl (R)-2-(((benzyloxy)carbonyl)amino)pent-4-enoate (2.50):
Benzyl (R)-2-aminopent-4-enoate 3.0 g (0.0079 mol) was added to a round-bottomed flask
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containing 20 mL H2O, 20 mL Et2O. Sodium bicarbonate 1.32 g (0.0158 mol) was then added at
RT and the reaction was cooled to 5o C. Benzyl chloroformate 1.24 mL (0.0087 mol) was added
dropwise over the next 1 h. The reaction was then allowed to stir overnight. The reaction was
then quenched with DCM/H2O and the organic layers were combined and dried with Na2SO4.
Then reaction was then filtered and solvent was removed under reduced pressure. Product was
precipitated using DCM/pentane to afford 1.8 g of pure product a 67 % yield.
[]D = 24.00 (c = 0.1, MeOH); 1H NMR (400 MHz, chloroform-d) δ 7.36 (s, 10H), 5.65 (td, J =
17.4, 7.2 Hz, 1H), 5.32 (d, J = 8.3 Hz, 1H), 5.24 – 4.96 (m, 6H), 4.52 (q, J = 5.9 Hz, 1H), 2.57
(dh, J = 20.4, 6.1 Hz, 2H).

Ethyl (E)-2-((tert-butylsulfinyl)imino)acetate (2.40):
Under an argon atmosphere (R)-(+)-tert-butanesulfinamide 5.0 g (0.0413 mol) was added to a
solution of ethyl glyoxylate in toluene (50 wt %) 8.19 mL (0.0413 mol) in a round bottom flask.
The reaction was heated to 50o C until a clear solution was obtained. MgSO4 9.94 g (0.0826 mol)
was added to the reaction and it was heated to 56o C for 20 h. Once the reaction was complete it
was filtered, and washed with toluene. The solvent was then removed under reduced pressure to
afford the product 6.70 g a pale yellow oil in a 79 % yield. All data obtained matched literature
reference.60
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1

H NMR (400 MHz, chloroform-d) δ 7.79 (s, 1H), 4.18 (q, J = 7.1 Hz, 2H), 1.18 (t, J = 7.1 Hz,

3H), 1.07 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 160.65, 155.30, 61.88, 58.29, 22.27, 13.75;
m/z ESI 260 (MNa+MeOH)

Ethyl (2R)-2-((t-butylsulfinyl)amino)pent-4-enoate (2.42):
Ethyl (E)-2-((t-butylsulfinyl)imino)acetate 1.0 g (0.00487 mol) was added to a round-bottomed
flask and a solution of saturated aqueous NaBr (25 mL) was added to the reaction stirring at
RT. Indium powder 2.24 g (0.0195 mol) was added to the reaction mixture followed by allyl
bromide 1.68 mL (0.0195 mol) and the reaction was allowed to stir overnight. Once the reaction
had reached completion, via TLC monitoring, it was quenched with saturated aqueous NaHCO3.
The reaction was extracted with EtOAc and dried over MgSO4 andthe organic layers were
combined and the solvent was removed under reduced pressure. The reaction was purified using
silica gel flash chromatography (EtOAc: hexanes; 6:4). The purification yielded 1.02 g of
product in 70 % yield. All data obtained matched literature reference.61
[]D = - 41.2; (c = 0.1, MeOH); 1H NMR (400 MHz, chloroform-d) δ 5.72 (d, J = 16.9 Hz, 1H),
5.10 (d, J = 10.4 Hz, 2H), 4.22 (dd, J = 7.1, 2.8 Hz, 2H), 4.02 (q, J = 6.1 Hz, 1H), 2.52 (q, J =
5.8 Hz, 2H), 1.28 (d, J = 7.2 Hz, 3H), 1.24 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 172.18,
132.30, 118.52, 61.43, 56.78, 55.88, 37.92, 22.43, 13.98; m/z ESI 248 (M+); m/z ESI 270
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(MNa+)

Diethyl (2R,7R,E)-2,7-bis((tert-butylsulfinyl)amino)oct-4-enedioate (2.43):
Ethyl (2R)-2-((tert-butylsulfinyl)amino)pent-4-enoate 4.0 g (0.00857 mol) was added to a roundbottomed flask charged with 40 mL degassed Et2O under an argon atmosphere. Next, 2 mol %
(140 mg) of Grubb’s second generation catalyst was added to the reaction as it continued to stir
at RT. Finally, 3 mol % of CuI (80 mg) was added and the mixture which was allowed to stir at
RT for 16 h. After, 16 h an additional portion (140 mg) of 2 mol % of Grubb’s second
generation catalyst was added and reaction continued to stir overnight. Reaction was then
quenched with H2O and tris(hydroxymethyl)phosphine (20 eq.) was added to the reaction. The
mixture was then extracted with EtOAc and the combined organic layers were dried with
MgSO4. Organic layers were then filtered and solvent was removed under reduced pressure. The
product 2.02 g (50 % yield) was purified by silica gel flash chromatography (CHCl3:Acetone;
90:10).
[]D = - 36.4; (c = 0.1, MeOH); 1H NMR (400 MHz, chloroform-d) δ 5.46 (t, J = 3.8 Hz, 2H),
4.25 – 4.12 (m, 6H), 3.98 (q, J = 5.9 Hz, 2H), 2.47 (t, J = 4.8 Hz, 4H), 1.29 (t, J = 7.1 Hz, 6H),
1.25 (s, 18H); 13C NMR (101 MHz, CDCl3) δ 172.21, 128.24, 77.40, 77.08, 76.76, 61.70, 56.96,
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56.04, 36.85, 22.60, 14.14; m/z ESI 466 (M+); m/z ESI 489 (MNa+)

Diethyl (2R,7R)-4-(((benzyloxy)carbonyl)amino)-2,7-bis((tert-butylsulfinyl)amino)-5hydroxyoctanedioate (2.44/ 2.45):
Diethyl (2R,7R,E)-2,7-bis((tert-butylsulfinyl)amino)oct-4-enedioate 1.0 g (0.00214 mol) was
added to a round bottom flask and charged with 40 mL MeCN:H2O (3:1). The reaction was
stirred at 0o C and benzyl (tosyloxy)carbamate 2.07 g (0.00643 mol) was added to the reaction
followed by 4 mol % potassium osmium(VI) oxide dehydrate (31.5 mg).The reaction stirred at 0o
C for 1 hr and then was allowed to warm up slowly to RT. After 5 h the reaction was complete
and the reaction was extracted with EtOAc. The combined organic layers were washed with
brine and dried with MgSO4. The organic layers were combined, filtered, and the solvent was
removed under reduced pressure. The product 0.607 g (45 % yield) was purified by silica gel
flash chromatography (Acetone: CHCl3: 35:65).
m/z ESI 634 (M+); m/z ESI 656 (MNa+);
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Diethyl (2R,4S,5S,7R)-4-(((benzyloxy)carbonyl)amino)-5-((4-bromobenzoyl)oxy)-2,7bis((tert-butylsulfinyl)amino)octanedioate; diethyl (2R,4R,5R,7R)-4(((benzyloxy)carbonyl)amino)-5-((4-bromobenzoyl)oxy)-2,7-bis((tertbutylsulfinyl)amino)octanedioate (2.46/2.47):
Diethyl (2R,7R)-4-(((benzyloxy)carbonyl)amino)-2,7-bis((tert-butylsulfinyl)amino)-5hydroxyoctanedioate 0.5 g (0.000789 mol) was added to a round bottom flask and charged with
50 mL anhydrous CH2Cl2 under an argon atmosphere. The reaction was then cooled to 0o C and
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 0.529 g (0.00276 mol) was
added and the reaction. Next, (dimethylamino)pyridine 0.222 g (0.00181 mol) was added to the
solution followed by p-bromobenzoic acid 0.745 g (0.00370 mol). The reaction was then allow
to warm to RT and continued to stir for 16 h. Once the reaction was complete it was quenched
with H2O and extract with DCM. Organic layers were combined and dried over Na2SO4, filtered,
and solvent was removed under reduced pressure. The products were purified using normal
phase HPLC using Water’s Nova-Pak column 19 x 300 mm (semi-prep). The retention time for
compound 1 was 7.5 min and retention time for compound 2 was 10 min.
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Compound 1
1

H NMR (400 MHz, chloroform-d) δ 7.82 (d, J = 8.5 Hz, 2H), 7.58 (d, J = 8.4 Hz, 2H), 7.37 –

7.28 (m, 5H), 5.42 (dt, J = 8.6, 4.0 Hz, 1H), 5.05 (s, 2H), 4.82 (d, J = 10.2 Hz, 1H), 4.43 (d, J =
6.3 Hz, 1H), 4.31 (d, J = 6.5 Hz, 1H), 4.28 – 4.20 (m, 1H), 4.12 (q, J = 6.5, 5.8 Hz, 4H), 4.06 –
3.90 (m, 3H), 2.29 (ddd, J = 14.2, 9.1, 5.0 Hz, 1H), 2.20 – 2.10 (m, 1H), 2.00 (t, J = 6.3 Hz, 2H),
1.28 (s, 18H), 1.22 – 1.15 (m, 6H);

Dibenzyl (2R,7R,E)-2,7-bis(((benzyloxy)carbonyl)amino)oct-4-enedioate (2.54):
Benzyl (R)-2-(((benzyloxy)carbonyl)amino)pent-4-enoate 0.5 g (0.0015 mol) was added to a
round bottom flaskand charged with 5 mL degassed Et2O under an argon atmosphere. Next, 2
mol % (0.025 mg) of Grubb’s second generation catalyst was added to the reaction as it
continued to stir at RT. Finally, 3 mol % of CuI (9 mg) was added and the mixture was allowed
to stir at reflux for 16 h. The mixture was then extracted with EtOAc and the combined organic
layers were dried with MgSO4. Organic layers were then filtered and solvent was removed under
reduced pressure. The product 0.188 g (41 % yield) was purified by silica gel flash
chromatography (EtoAc: Hexanes; 15:85). All data obtained matched literature reference.88
mp: 76-78 oC (Lit.87 mp: 73-74 oC); []D = 4.00 (c = 0.1, CHCl3); 1H NMR (400 MHz,
chloroform-d) δ 7.31 (s, 20H), 5.54 (d, J = 7.7 Hz, 1H), 5.27 (t, J = 3.9 Hz, 2H), 5.21 – 5.02 (m,
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8H), 4.43 (q, J = 6.6 Hz, 2H), 2.41 (q, J = 14.0 Hz, 4H); 13C NMR (101 MHz, CDCl3) δ 171.40,
155.76, 136.30, 135.29, 128.58, 128.45, 128.38, 128.09, 128.06, 67.14, 66.91, 53.56, 35.28. m/z
ESI 651 (M+); m/z ESI 673 (MNa+)
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